Jiang, Yixing <br/><br/>
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.  [electronic resource] 

 -  Cancer biology & therapy  Oct 2011 
 - 574-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.12.7.15971  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cell Line, Tumor<br/>Ceramides--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Drug Carriers--therapeutic use<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Glucosyltransferases--antagonists & inhibitors<br/>Humans<br/>Liposomes--therapeutic use<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Mice, Nude<br/>Morpholines--administration & dosage<br/>Nanoparticles--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine